After approving Covishield and Covaxin vaccines, the government has approved the Russian Sputnik-V vaccine on Monday.
Last week, Dr Reddy’s Laboratories had sought the government’s approval for the Sputnik-V vaccine for use in the country. The Hyderabad-based pharma major partnered with RDIF or The Russian Direct Investment Fund in September last year for conducting the clinical trials of Sputnik-V in the country.
Sputnik-V reportedly has an efficacy of 91.6%. Its Phase-III of clinical trials is being conducted in India, Venezuela, Belarus, and the UAE.